PROCEPT BioRobotics Financials - Benzinga

PROCEPT BioRobotics Corp

PRCTNASDAQ

Trade with Public

Trade with Public

$20.91

At close: Sep 2, 5:00 PM EST

$20.91

N/A

After Hours: 4:15 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

PROCEPT BioRobotics Financials

PROCEPT BioRobotics (PRCT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $397.424M Est

PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 million to $390.000 million-$410.000 million vs $397.424 million estimate.

Benzinga Newsdesk

PRO
PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M Estimate

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.46) by 2.17 percent. This is a 34.29 percent decrease over losses of $(0.35) per share

Benzinga Newsdesk

PRO
PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $396.674M Est

PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 million to $390.000 million-$410.000 million vs $396.674 million estimate.

Benzinga Newsdesk

PRO
PROCEPT BioRobotics Q1 EPS $(0.56), Inline, Sales $83.132M Beat $80.506M Estimate

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.56) per share which met the analyst consensus estimate. This is a 24.44 percent decrease over losses of $(0.45) per share from the same period last year.

Benzinga Newsdesk

Earnings Scheduled For April 29, 2026

Benzinga Insights

PROCEPT BioRobotics Stock Hits 52-Week Low - Here's Why

PROCEPT BioRobotics (NASDAQ: PRCT) shares down on Q4 2025 results and updated revenue guidance. Q1 sales expected at $79-82 million.

Vandana Singh